24/7 Customer Support
Valsad, Gujarat, India
WHO-GMP certified fluconazole 200mg tablets for enhanced antifungal therapy and severe infections with comprehensive global export capabilities.
| Strength | 200mg |
| Dosage Form | Tablets |
| Route | Oral |
| Indications | Severe infections, resistant cases, enhanced therapy |
| HS Code | 3004.20.90 |
| Regulatory Support | WHO-GMP, ISO 9001, CTD/eCTD dossier |
| Shelf Life | 24-36 months |
| Storage | Room temperature |
| Packaging Options | 10×10 blister packs, 30s, 100s, hospital packs |
| Target Markets | Specialty hospitals, referral centers, tertiary care |
Higher potency formulation for treatment of severe systemic fungal infections requiring enhanced therapeutic effect.
Effective management of fungal infections with resistance to lower doses, providing superior clinical outcomes.
Optimized for patients requiring higher drug exposure for effective treatment of complex fungal infections.
Valid WHO-GMP certification for international market access
Detailed COA with complete quality parameters
ICH-compliant stability studies for all climate zones
Complete registration dossier for global submissions
Contact our export team for competitive pricing, regulatory support, and seamless global supply chain solutions.